Disclosed are compounds of the following Formula (I) and tautomers, stereoisomers, isotopologues, solvates, polymorphs, or pharmaceutically acceptable salts thereof: Formula (I), wherein each of the variables R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , and L are defined below. Also disclosed is a method of treating a
disease or disorder mediated by
Formyl Peptide Receptor 1 (FPR1) with a compound of Formula (I) or a
tautomer, stereoisomer,
isotopologue, solvate, polymorph, or pharmaceutically acceptable salt thereof, and pharmaceutical compositions comprising the same.